Quantum Biopharma (QNTM) Shares Outstanding (Weighted Average) (2018 - 2026)

Quantum Biopharma has disclosed Shares Outstanding (Weighted Average) across 9 years of filings, most recently posting $4489.5 billion for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $4489.5 billion, up 81.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $4489.5 billion (up 81.39% YoY), and the FY2025 annual result was $3.3 million, down 97.82% from the prior year.
• Shares Outstanding (Weighted Average) came in at $4489.5 billion for Q1 2026 at Quantum Biopharma, down from $169551.0 billion in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $169551.0 billion in Q4 2025 to a low of $390000.0 in Q2 2023.
• The 5-year median for Shares Outstanding (Weighted Average) is $151.6 billion (2023), against an average of $22485.8 billion.
• Across the five-year window, Shares Outstanding (Weighted Average) slumped 99.74% in 2023 and jumped 10686094515.38% in 2024, its largest moves.
• Quantum Biopharma's Shares Outstanding (Weighted Average) stood at $143.4 million in 2022, then retreated by 3.93% to $137.8 million in 2023, then grew by 9.1% to $150.3 million in 2024, then soared by 112794335.9% to $169551.0 billion in 2025, then plunged by 97.35% to $4489.5 billion in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $4489.5 billion (Q1 2026), $169551.0 billion (Q4 2025), and $3801.2 billion (Q3 2025), per Business Quant data.